HBOC-201: The multi-purpose oxygen therapeutic

EuroIntervention

Volumn 4, Issue 1, 2008, Pages 161-165

  Dubé, Gregory P ^a   Vranckx, Pascal ^b   Gerson Greenburg, A ^a  

^a Biopure Corporation   (United States)

^b Department of Cardiology and Critical Care Medicine ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PANCREAS ENZYME; POLYMERIZED HEMOGLOBIN; BLOOD SUBSTITUTE; HEMOGLOBIN;

ABDOMINAL PAIN; ARTICLE; CARDIOVASCULAR PROCEDURE; CLINICAL EFFECTIVENESS; DIARRHEA; DRUG MANUFACTURE; DRUG SAFETY; DYSPHAGIA; ENZYME BLOOD LEVEL; FLATULENCE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MOLECULAR WEIGHT; NAUSEA AND VOMITING; OLIGURIA; OXYGEN DESATURATION; OXYGEN TENSION; OXYGEN THERAPY; OXYGEN TRANSPORT; SCLERA DISEASE; SIDE EFFECT; SKIN DISCOLORATION; TREATMENT INDICATION; ANEMIA; ANIMAL; BLEEDING; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANEMIA; ANIMALS; BLOOD LOSS, SURGICAL; BLOOD SUBSTITUTES; HEMOGLOBINS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 59249086424     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV4I1A26     Document Type: Article

References (19)

1. Rentko VT, Pearce LB, Moon-Massat PF, Gawryl MS. Hemopure (HBOC-201, Hemoglobin Glutamer-250 (Bovine)): Preclinical studies. Pages 424-436. In: RM Winslow, Editor, Academic Press, London, 2006.
2. Page TC, Light WR, Hellums JD. Prediction of microcirculatory oxygen transport by erythrocyte/hemoglobin solution mixtures. Microvasc Res. 1998;56:113-126.
3. Mortimer P. Making blood safer: Stricter vigilance and fewer transfusions are the way forward. Brit Med J. 2002;325:400-401.
4. Jahr JS, MacKenzie C, Pearce LB, Pitman A, Greenburg AG. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J. Trauma. 2008; in press.
5. Serruys PW, Vranckx P, Slagboom T, Regar E, Meliga E, de Winter R.J, Heyndrickx G, van Remortel EAM, Dubé GP and Symons J for the COR-0001 trial investigators. Hemodynamic effects, safety, and tolerability of hemoglobin-based oxygen carrier-201 (HBOC-201) in patients undergoing PCI for CAD. EuroInterv. 2008;3:600-609.
6. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-414.
7. Meliga E, Vranckx P, Regar E, Kint PP; Duncker DJ, Serruys PW. COR-0002: Proof-of-concept trial to evaluate hemoglobin based oxygen therapeutics in elective percutaneous coronary revascularization. Rationale, protocol design and hemodynamic results. Submitted for publication, EuroInterv. 2008;4:99-107.
8. Pearce LB, Pitman AN, Greenburg AG. Results of research with haemoglobin-based oxygen carriers (HBOCs): Evidence of toxicity or failure to assess relative efficacy? Sumitted for publication.
9. Pearce LB, Pitman AN. Risk of adverse outcome due to acute anemia in the orthopedic surgical setting. Clin Pharmacol Ther. 2008 (Abstract accepted).
10. Gurney J, Philbin N, Rice J, Arnaud F, Dong F, Wulster-Radcliffe M, Pearce LB, Kaplan L, McCarron R, Freilich D. A hemoglobin based oxygen carrier, bovine polymerized hemoglobin (HBOC-201) versus Hetastarch (HEX) in an uncontrolled liver injury hemorrhagic shock swine model with delayed evacuation. J Trauma. 2004;57:726-738.
11. Patel MB, Feinstein AJ, Saenz AD, Majetschak M, Proctor KG. Prehospital HBOC-201 after traumatic brain injury and hemorrhagic shock in swine. J Trauma. 2006;61:46-56.
12. Manning JE, Katz LM, Brownstein MR, Pearce LB, Gawryl MS, Baker CC. Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Carolina Resuscitation Research Group. Shock. 2000;13:152-159.
13. Horn EP, Standl T, Wilhelm S, Jacobs EE, Freitag U, Freitag M, Schulte am Esch J. Bovine hemoglobin increases skeletal muscle oxygenation during 95% artificial arterial stenosis. Surgery. 1997;121:411-418.
14. Caswell JE, Strange MB, Rimmer DM, III, Gibson MF, Cole P, Lefer DJ. A novel hemoglobin-based blood substitute protects against myocardial reperfusion injury. Am J Physiol Heart Circ Physiol. 2005;288:H1796-H1801.
15. George I, Yi G, Schulman AR, Morrow BT, Cheng Y, Gu A, Zhang G, Oz MC, Burkhoff D, Wang J. A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia. Am J Physiol Heart Circ Physiol. 2004;291(3):H1126-H1137.
16. Mongan PD, Moon-Massat PF, Rentko V, Mihok S, Sharma P. Regional blood flow following serial normovolemic exchange transfusion with HBOC-201 (Hemopure) in anesthetized swine. Submitted for publication.
17. Reffelmann T, Kloner RA. The no-reflow phenomenon: basic science and clinical correlates. Heart 2002;87:162-168.
18. Carlier S, Qian J, Schmitt J, Wang Jie, Leon MB. Oxygenated Hemopure offers clear visualization of coronary arteries during OCT imaging without ischemia. J Am Coll Cardiol. 47 (Suppl. B), 2006.
19. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998-3002.